Litigation Details for Rochester Drug Co-Operative, Inc. v. Allergan, Inc. (E.D.N.Y 2018)
✉ Email this page to a colleague
Rochester Drug Co-Operative, Inc. v. Allergan, Inc. (E.D.N.Y 2018)
| Docket | ⤷ Try a Trial | Date Filed | 2018-02-14 |
| Court | District Court, E.D. New York | Date Terminated | 2023-08-01 |
| Cause | 28:1331 Fed. Question: Anti-trust | Assigned To | Nina Gershon |
| Jury Demand | Plaintiff | Referred To | Lois Bloom |
| Patents | 8,633,162; 8,642,556; 8,648,048; 8,685,930; 9,248,191 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Rochester Drug Co-Operative, Inc. v. Allergan, Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Try a Trial .
Details for Rochester Drug Co-Operative, Inc. v. Allergan, Inc. (E.D.N.Y 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2017-12-11 | 1 | early 2014 as U.S. Patent Nos. 8,629,111 (“the ’111 patent”), 8,633,162 (“the ’162 patent”), 8,642,556 (… Jan. 14, 2014); U.S. Patent No. 8,633,162 (dated Jan. 21, 2014); U.S. Patent No. 8,642,556 (dated Feb…1995 as U.S. Patent No. 5,474,979 (“the ’979 patent” or “the Ding I patent”). The Ding I patent 2 National… The second patent, U.S. Patent No. 5,981,607 (“the ’607 patent” or “the Ding II patent”), is titled…enjoyed a patent- protected monopoly, originating from U.S. Patent No. 5,474,979 (the “’979 Patent” or “Ding | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
